Buprenorphine And Naloxone Film
Product Images NDC 0378-8765

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0378-8765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Hydrochloride Structural Formula (Image 01)

Chemical structure of Buprenorphine hydrochloride, showing molecular bonds and arrangement of atoms.*

FDA Label Image

Naloxone Hydrochloride Structural Formula (Image 02)

Chemical structure of naloxone, including four chiral centers marked with asterisks, connected with notation for HCl and 2H2O hydration.*

FDA Label Image

Instructions For Use Figure 1 (Image 03)

An instructional illustration showing hands using scissors to cut open a sealed foil packet containing a buccal or sublingual film, demonstrating how to access the film for administration.*

FDA Label Image

Instructions For Use Figure 2 (Image 04)

Illustration showing the placement of a buprenorphine and naloxone film inside the mouth on the tongue. The mouth is open, displaying the teeth and tongue with the film positioned on the tongue, indicating the buccal or sublingual administration route.*

FDA Label Image

Instructions For Use Figure 3 (Image 05)

Illustrations showing the placement of a buprenorphine and naloxone film inside the mouth. One image demonstrates positioning the film on the inside of the lower lip (buccal route), and the other shows the film placed under the tongue (sublingual route). The grayscale drawings emphasize correct film placement for administration.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 06)

Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Mylan Pharmaceuticals Inc. The label indicates a box containing 30 pouches each with one sublingual film. Directions for sublingual and buccal administration, storage conditions, warnings, and manufacturer information are included on the label along with NDC 0378-8765-93 and an Rx only designation.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 07)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Mylan Pharmaceuticals Inc. The carton is white with blue accents and includes the product name, dosage form, strength, and instructions for use. It indicates the product contains 30 sublingual film pouches, each with specified doses. The label also has warnings about accidental ingestion and directions not to cut, chew, or swallow the film.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 08)

Packaging label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Mylan Pharmaceuticals Inc. The label includes dosage instructions, storage conditions, and warnings about accidental ingestion by children. The package contains 30 pouches, each with one sublingual film. The label features the NDC 0378-8767-93 and emphasizes the buccal and sublingual administration routes.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 09)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 12 mg/3 mg strength, from Mylan Pharmaceuticals Inc. The label indicates the product is a human prescription drug for buccal and sublingual use. The box contains 30 pouches, each with one sublingual film. The label includes dosage instructions, safety warnings, and manufacturer details, along with NDC 0378-8768-93 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.